Johnson & Johnson has granted Stop TB Partnership license to produce generic bedaquiline in low and middle-income countries medicine Link 33 votes
An open letter to Johnson & Johnson regarding its strategy to extend its patent on bedaquiline leading to a predicted six million lives lost over four years medicine Video 7:25 79 votes
'This case will set a precedent': First major opioid trial to begin in Oklahoma medicine Article 1180 words 4 votes
Johnson & Johnson knew for decades that asbestos lurked in its baby powder Article 3038 words, published Dec 14 2018 11 votes